{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:26:14Z","timestamp":1779290774370,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.advms.2020.01.002","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T18:05:17Z","timestamp":1579284317000},"page":"156-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Treatment and its side effects in ANCA-associated vasculitides \u2013 Study based on POLVAS registry data"],"prefix":"10.1016","volume":"65","author":[{"given":"Grzegorz","family":"Biedro\u0144","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"W\u0142udarczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Wawrzycka-Adamczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"W\u00f3jcik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Sznajd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zbigniew","family":"Zdrojewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Masiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zenobia","family":"Czuszy\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Majdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rados\u0142aw","family":"Jeleniewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Klinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Jakuszko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olumide Olatubosun","family":"Rowaiye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Brzosko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwona","family":"Brzosko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicja","family":"D\u0119bska-\u015alizie\u0144","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Storoniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Witold","family":"T\u0142ustochowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Kur-Zalewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Wis\u0142owska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Madej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Hawrot-Kawecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"G\u0142uszko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugeniusz J.","family":"Kucharz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Musia\u0142","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Szczeklik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.advms.2020.01.002_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"Revised international Chapel Hill Consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.advms.2020.01.002_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.berh.2004.11.006","article-title":"What is known about the epidemiology of the vasculitides?","volume":"19","author":"Watts","year":"2005","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.advms.2020.01.002_bib3","series-title":"EUCERD Core Recommendations on Rare Disease Patient Registration and Data Collection","year":"2013"},{"issue":"3","key":"10.1016\/j.advms.2020.01.002_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.20452\/pamw.2146","article-title":"Rare disease registries: an initiative to establish vasculitis registry in Poland","volume":"124","author":"Padjas","year":"2014","journal-title":"Pol. Arch. Med. Wewn."},{"issue":"1","key":"10.1016\/j.advms.2020.01.002_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.20452\/pamw.3920","article-title":"Polish vasculitis registry: POLVAS","volume":"127","author":"Musial","year":"2017","journal-title":"Pol. Arch. Intern. Med."},{"issue":"8","key":"10.1016\/j.advms.2020.01.002_bib6","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/art.1780330803","article-title":"The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods","volume":"33","author":"Bloch","year":"1990","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.advms.2020.01.002_bib7","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.2215\/CJN.00100114","article-title":"Long-term follow-up of cyclophosphamide compared with azathioprine for initial maintenance therapy in ANCA-associated vasculitis","volume":"9","author":"Walsh","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.advms.2020.01.002_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.advms.2020.01.002_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.advms.2020.01.002_bib10","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1007\/s10067-019-04538-w","article-title":"Clinical characteristics of Polish patients with ANCA-associated vasculitides-retrospective analysis of POLVAS registry","volume":"38","author":"Wojcik","year":"2019","journal-title":"Clin. Rheumatol."},{"issue":"8","key":"10.1016\/j.advms.2020.01.002_bib11","article-title":"Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity","volume":"96","author":"Solans-Laque","year":"2017","journal-title":"Medicine (Baltim.)"},{"issue":"3","key":"10.1016\/j.advms.2020.01.002_bib12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6","article-title":"Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients","volume":"42","author":"Guillevin","year":"1999","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.advms.2020.01.002_bib13","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.advms.2020.01.002_bib14","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/rheumatology\/kep304","article-title":"Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa","volume":"48","author":"Mohammad","year":"2009","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.advms.2020.01.002_bib15","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/ard.2008.088302","article-title":"Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients","volume":"68","author":"Charlier","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.advms.2020.01.002_bib16","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.advms.2020.01.002_bib17","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1093\/rheumatology\/ket445","article-title":"BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis","volume":"53","author":"Ntatsaki","year":"2014","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.advms.2020.01.002_bib18","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/annrheumdis-2011-200477","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up","volume":"71","author":"Harper","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.advms.2020.01.002_bib19","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"150","author":"de Groot","year":"2009","journal-title":"Ann. Intern. Med."},{"issue":"26","key":"10.1016\/j.advms.2020.01.002_bib20","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1056\/NEJMoa0802311","article-title":"Azathioprine or methotrexate maintenance for ANCA-associated vasculitis","volume":"359","author":"Pagnoux","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.advms.2020.01.002_bib21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/art.27763","article-title":"Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades","volume":"63","author":"JU","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.advms.2020.01.002_bib22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/rheumatology\/37.6.659","article-title":"Wegener's granulomatosis: long-term follow-up of patients treated with pulse cyclophosphamide","volume":"37","author":"Koldingsnes","year":"1998","journal-title":"Br. J. Rheumatol."},{"issue":"4","key":"10.1016\/j.advms.2020.01.002_bib23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2796.2008.02060.x","article-title":"Improved outcome in Wegener's granulomatosis and microscopic polyangiitis? A retrospective analysis of 95 cases in two cohorts","volume":"265","author":"Eriksson","year":"2009","journal-title":"J. Intern. Med."},{"issue":"2","key":"10.1016\/j.advms.2020.01.002_bib24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/rheumatology\/kez001","article-title":"A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"58","author":"Pepper","year":"2019","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.advms.2020.01.002_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/BOR.0000000000000015","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): evolutions in classification, etiopathogenesis, assessment and management","volume":"26","author":"Mahr","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"issue":"1","key":"10.1016\/j.advms.2020.01.002_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12016-011-8266-y","article-title":"Cutting edge issues in the Churg-Strauss syndrome","volume":"44","author":"Szczeklik","year":"2013","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.advms.2020.01.002_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2014.08.055","article-title":"Noncorticosteroid immunosuppression limits myocardial damage and contractile dysfunction in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)","volume":"65","author":"Miszalski-Jamka","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3 Suppl 82","key":"10.1016\/j.advms.2020.01.002_bib28","first-page":"S41","article-title":"ANCA-positive and ANCA-negative phenotypes of eosinophilic granulomatosis with polyangiitis (EGPA): outcome and long-term follow-up of 50 patients from a single Polish center","volume":"32","author":"Sokolowska","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.advms.2020.01.002_bib29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/ndt\/gfw046","article-title":"End-stage renal disease in ANCA-associated vasculitis","volume":"32","author":"Moiseev","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"issue":"7","key":"10.1016\/j.advms.2020.01.002_bib30","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3899\/jrheum.131038","article-title":"A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis","volume":"41","author":"Mohammad","year":"2014","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.advms.2020.01.002_bib31","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.33361","article-title":"Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"64","author":"Walsh","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.advms.2020.01.002_bib32","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1002\/art.23800","article-title":"Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts","volume":"58","author":"Pagnoux","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.advms.2020.01.002_bib33","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/art.27340","article-title":"Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: a prospective randomized study of one hundred twenty-four patients","volume":"62","author":"Ribi","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.advms.2020.01.002_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1681\/ASN.V7123","article-title":"Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis","volume":"7","author":"Hogan","year":"1996","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.advms.2020.01.002_bib35","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1007\/s10067-018-4100-8","article-title":"Late restoration of renal function in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation","volume":"37","author":"Ma","year":"2018","journal-title":"Clin. Rheumatol."},{"issue":"5","key":"10.1016\/j.advms.2020.01.002_bib36","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2215\/CJN.08290813","article-title":"Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure","volume":"9","author":"Lee","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.advms.2020.01.002_bib37","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1681\/ASN.2007010066","article-title":"Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis","volume":"18","author":"de Lind van Wijngaarden","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.advms.2020.01.002_bib38","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12882-018-0933-2","article-title":"Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study","volume":"19","author":"Yang","year":"2018","journal-title":"BMC Nephrol."},{"issue":"9","key":"10.1016\/j.advms.2020.01.002_bib39","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrneph.2012.107","article-title":"Complications of long-term therapy for ANCA-associated systemic vasculitis","volume":"8","author":"Wall","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"issue":"Suppl 1","key":"10.1016\/j.advms.2020.01.002_bib40","doi-asserted-by":"crossref","first-page":"i164","DOI":"10.1093\/ndt\/gfu406","article-title":"Getting the balance right: adverse events of therapy in anti-neutrophil cytoplasm antibody vasculitis","volume":"30","author":"Wong","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"issue":"6","key":"10.1016\/j.advms.2020.01.002_bib41","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Rev. Infect. Dis."},{"issue":"3","key":"10.1016\/j.advms.2020.01.002_bib42","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.2010.137778","article-title":"Long-term patient survival in ANCA-associated vasculitis","volume":"70","author":"Flossmann","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.advms.2020.01.002_bib43","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1002\/art.39317","article-title":"Incidence of malignancies in patients with antineutrophil cytoplasmic antibody-associated vasculitis diagnosed between 1991 and 2013","volume":"67","author":"Rahmattulla","year":"2015","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.advms.2020.01.002_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126016","article-title":"Incidence of cancer in ANCA-associated vasculitis: a meta-analysis of observational studies","volume":"10","author":"Shang","year":"2015","journal-title":"PLoS One"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S189611262030002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S189611262030002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:42:37Z","timestamp":1761824557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S189611262030002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S189611262030002X"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2020.01.002","relation":{},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment and its side effects in ANCA-associated vasculitides \u2013 Study based on POLVAS registry data","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2020.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V. on behalf of Medical University of Bialystok.","name":"copyright","label":"Copyright"}]}}